AHRQ Healthcare Innovations Exchange Innovator Interview and AHRQ Healthcare Innovations Exchange Innovator Email Submission Guidelines

Forms and Documents

Document Name	Status
Form Form #4 Annual follow-up interview Form and Instruction	New
Form Form #3 Health care innovator interview - without email submission Form and Instruction	New
Form Form #2 Health care innovator interview -following email submission Form and Instruction	New
Form Form #1 Email submission Form	New
List_Inclusion_Exclusion_Criteria_Final.doc Supplementary Document	2009-03-12
OMB passbacks.doc Supplementary Document	2009-03-12
Response to OMB Questions of January 12 09_NIX.doc Supplementary Document	2009-03-12
Attachment G -- Expert Consultation.doc Supplementary Document	2008-11-03
Attachment F -- 60 Day FRN -- AHRQ Healthcare Innovations Exchange Interview & Submission Guidlines.pdf Supplementary Document	2008-11-03
Attachment E -- List of Websites.doc Supplementary Document	2008-11-03
Supporting Statement -- Innovations Exchange 11-3-2008.doc Supporting Statement A	2008-11-03

IC Document Collections

IC ID	Document Title	Status
187246	Annual follow-up interview Form and Instruction	New
187245	Health care innovator interview - without email submission Form and Instruction	New
187244	Health care innovator interview -following email submission Form and Instruction	New
187243	Email submission Form	New

ICR Details

OMB Control No: 0935-0147	ICR Reference No: 200811-0935-001
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/AHRQ	Agency Tracking No:
Title: AHRQ Healthcare Innovations Exchange Innovator Interview and AHRQ Healthcare Innovations Exchange Innovator Email Submission Guidelines
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 03/16/2009
	Date Received in OIRA: 11/17/2008
Terms of Clearance: This ICR is approved for 24 months under the following conditions in order to provide for a trial run of this database: (1) During the intial round of applications, AHRQ agrees to compile the questions that come in about this ICR from interested applicants and prepare FAQs for future rounds of applications. These FAQs will be included with the request for renewal. (2) AHRQ agrees to also collect data on how many applications it receives and how many applications are ultimately included in the healthcare innovations database. This data will also be included in the request for renewal. AHRQ will also compile a list of why the excluded applications were excluded and use this information in the request for renewal to refine the inclusion/exclusion criteria. At that time, AHRQ should also determine more concretely whether this database is intended to be a showcase for AHRQ’s funded projects or a database of innovative interventions. In order for this database to be both, AHRQ would have to demonstrate that truly innovative interventions that were not funded by AHRQ were excluded if and only if they were of a lower evidence rating and/or less innovative in terms of how AHRQ is defining the term “innovative.” (3) AHRQ will also prepare some kind of plan for evaluating the utility of this project (e.g. through customer satisfication surveys). This will require AHRQ to somehow “track” who comes to this website so that they can be surveyed at a later time about their satisfaction with the database. (4) Since the main users of this database will be those working on the front-lines of quality improvement and looking for solutions to their problems, providing data on innovations that did not work seems to have limited utility. However, since there can be utility in knowing what innovations failed for researchers or those who are trying to come up with innovations, information about failed innovations can be part of the database as long as they are listed separately from those innovations that seem to have worked. AHRQ agrees to separate the effective/efficacious innovations from the failed innovations so that visitors to the database can easily find what they are looking for. (5) The inclusion and exclusion criteria will be provided as part of the instructions to applicants. (6) AHRQ agrees to include its priorities (as listed in the supporting statement) in the instructions to applicants so that applicants understand the criteria on which they are being judged. (7) AHRQ agrees to place the evidence rating in the first section where the innovation is summarized so that visitors to the database can easily determine which innovations have what level of evidence rating. (8) AHRQ agrees to limit the database section that includes innovations that worked to those that are at least “suggestive” on the evidence rating scale (i.e. "unproven" innovations will not be included). (9) Consistent with AHRQ memo of 1/12/09, AHRQ will provide the definition for “truly innovative” in its instructions and requests for applications so that applicants understand more clearly what type of innovations AHRQ is looking for(i.e. "For the purposes of the AHRQ Health Care Innovations Exchange, innovation refers to the creative implementation of new or altered products, services, processes, systems, organizational structures, or business models as a means of improving one or more domains of health care quality. In this context, the Health Care Innovations Exchange sees innovations as activities that are generally perceived as new in a particular setting or for a particular population relative to the usual care delivery processes. Applying that view to this work, the Health Care Innovations Exchange team will assess the novelty of quality improvement initiatives/efforts against usual care delivery (or care processes). The context and conditions of the novel approach to improving quality are important elements in making that assessment.In addition to brand new ideas, the Health Care Innovations Exchange will welcome activities adapted from other industries to health care, transferred from one health care setting or market segment to another, drawn from settings in other countries, or applied to a new or different patient population. Innovators must be able to communicate to the Health Care Innovations Exchange team how their innovations differ from what is regarded as standard practice in their organizations and among similar organizations. The Health Care Innovations Exchange team will couple their working knowledge of the industry (and the knowledge of experts) with the innovators’ perspective in making a final decision about novelty.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2011	36 Months From Approved
Responses	566	0	0
Time Burden (Hours)	401	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: The Innovations Exchange will provide a national-level information hub to foster the implementation and adaptation of innovative strategies that improve health care quality and minimize disparities in the care received by different populations. It is intended to address stakeholder interest in a "one-stop shop" that presents digested and reliable information about health care delivery innovations along with their accompanying implementation tools and networking opportunities to share implementation strategies and techniques. Its target audiences, broadly defined, will be current and potential change agents in the U.S. health care system, including clinicians (e.g., physicians, nurses, and other providers), health system administrators, health plan managers, health service purchasers, regulators, and policymakers from relevant Federal and state agencies.

---

Authorizing Statute(s): US Code: 42 USC 299 Name of Law: Healthcare Research and Quality Act of 1999
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	73 FR 49462	08/21/2008
30-day Notice:	Federal Register Citation:	Citation Date:
	73 FR 64954	10/31/2008
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 4

IC Title	Form No.	Form Name
Email submission	Form #1	AHRQ Healthcare Innovations Exchange Innovator Email Submission Guidelines
Health care innovator interview -following email submission	Form #2	Innovator Interview Guide for Email Submissions
Health care innovator interview - without email submission	Form #3	Innovator Interview Guide
Annual follow-up interview	Form #4	Annual follow-up interview

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	566	0	0	566	0	0
Annual Time Burden (Hours)	401	0	0	401	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This request for OMB clearance is for a new information collection.

---

Annual Cost to Federal Government: $38,873

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 11/17/2008

---